课题基金 / 基金详情

Accurate and Individualized Prediction of Excitation-Inhibition Imbalance in Alzheimer's Disease using Data-driven Neural Model

Accurate and Individualized Prediction of Excitation-Inhibition Imbalance in Alzheimer's Disease using Data-driven Neural Model
使用数据驱动的神经模型准确、个性化地预测阿尔茨海默病的兴奋抑制失衡
批准号:
10727356
负责人:
GUOSHI LI
金额:
$42.76万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2025-08-31

项目摘要

项目成果

GUOSHI LI的其他基金

相似基金

相关文献

中文摘要
翻译
兴奋-抑制失衡的准确和个性化预测
英文摘要
Accurate and Individualized Prediction of Excitation-Inhibition Imbalance in Alzheimer’s Disease using Data-driven Neural Model Project Summary/Abstract Alzheimer’s disease (AD) is the most common form of dementia characterized by progressive and irreversible cognitive decline. Despite its devastating impacts on the US health care system, its precise etiology and effective treatment options are still lacking. Recent animal studies and human neuroimaging data indicate disrupted excitation-inhibition (E-I) balance in AD which may serve as important pathophysiological and therapeutic target. However, existing analytical techniques in functional MRI (fMRI) do not allow for E-I mapping at cellular and circuit levels. To overcome these limitations, we have developed a Multiscale Neural Model Inversion (MNMI) framework based on resting-state fMRI (rs-fMRI) and diffusion MRI (dMRI) to detect circuit-level E-I imbalance in neuronal networks underlying disease conditions. The goal of this project is to validate and refine the MNMI framework for accurate and individualized estimation of E-I imbalance in AD. To achieve this goal, we will pursue two specific aims. In Aim 1, we will predict disrupted E-I balance in an AD mouse model using MNMI of rs-fMRI. We will first perform ZTE-fMRI and dMRI on wild-type (WT) control and 3xTg-AD (TG) mice. We will then apply the MNMI model to predict regional E-I balance based on rs-fMRI and dMRI and derive areas with E-I impairments in AD mice. Based on MNMI predictions we will select four brain regions (three with the most significant E-I impairments in TG mice plus one control region) for in vivo optical measurements. In Aim 2, we will validate the MNMI model predictions using in vivo optical E-I measurements and behavioral testing. We will first perform simultaneous ZTE-fMRI and fiber photometry (at the four selected sites) in a different set of age-matched WT and TG mice as Aim 1. We will then validate the model predictions at both individual subject and group levels and improve the MNMI framework if model predictions deviate from empirical E-I measures. Lastly, we will examine if the E-I imbalance in TG mice is associated with cognitive impairments. The overarching goal of our research is to combine computational modeling, fMRI, and cutting-edge neuromodulation and recording tools to delineate pathological network activity, elucidate the underlying circuit mechanisms, and develop more effective treatment modalities for AD. Successful implementation of this project will lead to an innovative computational framework that serves to identify pathological E-I imbalance using noninvasive MRI and facilitates the development of new diagnostic technique and personalized treatment for detecting and restoring E-I imbalance in early intervention. The proposed work is also of broader significance to the fields of neuroscience, neuroimaging, psychiatry, and psychology since novel tools will be developed to enable the identification of E-I balance in health and imbalance in diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamical Mechanisms of External Tufted Cells in Olfactory Information Processing
Dynamical Mechanisms of External Tufted Cells in Olfactory Information Processing
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: